Morgan Stanley - Dec 31, 2024 SCHEDULE 13G Report for Syndax Pharmaceuticals Inc Common Stock (SNDX)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Security
Syndax Pharmaceuticals Inc Common Stock
Symbol
SNDX
Shares outstanding
85.1M shares
Disclosed Ownership
5.36M shares
Ownership
6.3%
Form type
SCHEDULE 13G
Date filed
2/5/2025, 10:03 AM
Date of event
Dec 31, 2024
Next filing
May 7, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 6.3% 5.36M 0 5.31M Christopher O'Hara Authorized Signatory, Morgan Stanley
Morgan Stanley & Co. LLC 5.9% 5.06M 0 5.06M Christopher O'Hara Authorized Signatory, Morgan Stanley & Co. LLC